Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study.
van den Broek M, Klarenbeek NB, Dirven L, van Schaardenburg D, Hulsmans HM, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF. van den Broek M, et al. Among authors: dirven l. Ann Rheum Dis. 2011 Aug;70(8):1389-94. doi: 10.1136/ard.2010.147751. Epub 2011 Apr 24. Ann Rheum Dis. 2011. PMID: 21515916 Clinical Trial.
Depression and anxiety in glioma patients.
van der Meer PB, Dirven L, Hertler C, Boele FW, Batalla A, Walbert T, Rooney AG, Koekkoek JAF. van der Meer PB, et al. Among authors: dirven l. Neurooncol Pract. 2023 Apr 20;10(4):335-343. doi: 10.1093/nop/npad019. eCollection 2023 Aug. Neurooncol Pract. 2023. PMID: 37457222 Free PMC article. Review.
Development of a core outcome set for use in adult primary glioma phase III interventional trials: A mixed methods study.
Retzer A, Baddeley E, Sivell S, Scott H, Nelson A, Bulbeck H, Seddon K, Grant R, Adams R, Watts C, Aiyegbusi OL, Kearns P, Rivera SC, Dirven L, Calvert M, Byrne A. Retzer A, et al. Among authors: dirven l. Neurooncol Adv. 2023 Aug 2;5(1):vdad096. doi: 10.1093/noajnl/vdad096. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37719788 Free PMC article.
Corrigendum to: Palliative care and end-of-life care in adults with malignant brain tumors.
Koekkoek JAF, van der Meer PB, Pace A, Hertler C, Harrison R, Leeper HE, Forst DA, Jalali R, Oliver K, Philip J, Taphoorn MJB, Dirven L, Walbert T. Koekkoek JAF, et al. Among authors: dirven l. Neuro Oncol. 2023 Jan 5;25(1):212. doi: 10.1093/neuonc/noac252. Neuro Oncol. 2023. PMID: 36610983 Free PMC article. No abstract available.
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures.
Pe M, Alanya A, Falk RS, Amdal CD, Bjordal K, Chang J, Cislo P, Coens C, Dirven L, Speck RM, Fitzgerald K, Galinsky J, Giesinger JM, Holzner B, Le Cessie S, O'Connor D, Oliver K, Pawar V, Quinten C, Schlichting M, Ren J, Roychoudhury S, Taphoorn MJB, Velikova G, Wintner LM, Griebsch I, Bottomley A; SISAQOL-IMI Consortium. Pe M, et al. Among authors: dirven l. Lancet Oncol. 2023 Jun;24(6):e270-e283. doi: 10.1016/S1470-2045(23)00157-2. Lancet Oncol. 2023. PMID: 37269858 Free article. Review.
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types.
Musoro JZ, Coens C, Sprangers MAG, Brandberg Y, Groenvold M, Flechtner HH, Cocks K, Velikova G, Dirven L, Greimel E, Singer S, Pogoda K, Gamper EM, Sodergren SC, Eggermont A, Koller M, Reijneveld JC, Taphoorn MJB, King MT, Bottomley A; EORTC Melanoma, Breast, Head and Neck, Genito-urinary, Gynecological, Gastro-intestinal, Brain, Lung and Quality of Life Groups. Musoro JZ, et al. Among authors: dirven l. Eur J Cancer. 2023 Jul;188:171-182. doi: 10.1016/j.ejca.2023.04.027. Epub 2023 May 7. Eur J Cancer. 2023. PMID: 37257278 Free article.
Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated TERT promoter mutation.
Wijnenga MMJ, Maas SLN, van Dis V, Tesileanu CMS, Kros JM, Dirven L, Hazelbag HM, Dubbink HJ, Vincent AJPE, French PJ, van den Bent MJ. Wijnenga MMJ, et al. Among authors: dirven l. Neurooncol Adv. 2023 Jun 21;5(1):vdad075. doi: 10.1093/noajnl/vdad075. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37441086 Free PMC article. No abstract available.
Changes in hand bone mineral density and the association with the level of disease activity in patients with rheumatoid arthritis: bone mineral density measurements in a multicenter randomized clinical trial.
Dirven L, Güler-Yüksel M, de Beus WM, Ronday HK, Speyer I, Huizinga TW, Dijkmans BA, Allaart CF, Lems WF. Dirven L, et al. Arthritis Care Res (Hoboken). 2011 Dec;63(12):1691-9. doi: 10.1002/acr.20612. Arthritis Care Res (Hoboken). 2011. PMID: 21905248 Free article. Clinical Trial.
162 results